Molecular Health, based in Heidelberg, Germany, makes software that turns biomedical data into insights for drug development.
Founded in 2004 in Heidelberg, Germany, Molecular Health develops software that integrates biomedical data with therapeutic insights. Its MH Guide Case Annotation Solution links tumor alteration data to published therapy associations, biomarkers and clinical trials, and its Dataome Technology supports analytics. Revenue comes mainly from subscriptions. Hartmut Voss is the founder and Friedrich Von Bohlen is CEO. The company has received EUR 25.00 mn in funding, mainly from Dievini.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in